Sofie Isebaert

2.5k citations

63 papers · 1.8k indexed · 1 hit paper · h-index 23

Impact in

Radiation top 1%
- Advanced Radiotherapy Techniques
Pulmonary and Respiratory Medicine top 2%
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research

Papers in ⓘ

Radiation 15
- Advanced Radiotherapy Techniques 15
Pulmonary and Respiratory Medicine 34
- Prostate Cancer Diagnosis and Treatment 27
- Prostate Cancer Treatment and Research 24

Co-authors: Karin Haustermans (56 shared papers)Annelies Gonnissen (7 shared papers)Laura Van den Bergh (13 shared papers)Uulke A. van der Heide (17 shared papers)Floris J. Pos (17 shared papers)Robert Jan Smeenk (16 shared papers)Linda G.W. Kerkmeijer (14 shared papers)Steven Joniau (20 shared papers)
Journals: Radiotherapy and Oncology (18 papers)International Journal of Radiation Oncology*Biology*Physics (6 papers)Acta Oncologica (4 papers)International Journal of Molecular Sciences (3 papers)Oncotarget (2 papers)
Partner nations: Belgium Netherlands United States

In The Last Decade

Sofie Isebaert

61 papers receiving 1.8k citations

Hit Papers

align trajectories log scale

Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: Results From the FLAME Randomized Phase III Trial 2021 · 299 citations

Peers

Countries citing papers authored by Sofie Isebaert

Since Specialization

Citations

This map shows the geographic impact of Sofie Isebaert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofie Isebaert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofie Isebaert more than expected).

Fields of papers citing papers by Sofie Isebaert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofie Isebaert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofie Isebaert. The network helps show where Sofie Isebaert may publish in the future.

Co-authors

The 25 scholars most cited alongside Sofie Isebaert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sofie Isebaert Line = papers co-authored together Sofie Isebaert links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: Results From the FLAME Randomized Phase III Trial Journal of Clinical Oncology ·Linda G.W. Kerkmeijer, V. Groen, Floris J. Pos, Karin Haustermans, Evelyn M. Monninkhof, Robert Jan Smeenk, Martina Kunze-Busch, Johannes C.J. de Boer, Jochem van der Voort van Zijp, Marco van Vulpen, Cédric Draulans, Laura Van den Bergh, Sofie Isebaert, Uulke A. van der Heide Hit paper breakdown →	2021	299
2	Targeting the Hedgehog signaling pathway in cancer: beyond Smoothened Oncotarget ·Annelies Gonnissen, Sofie Isebaert, Karin Haustermans	2015	148
3	Multiparametric MRI for prostate cancer localization in correlation to whole‐mount histopathology Journal of Magnetic Resonance Imaging ·Sofie Isebaert, Laura Van den Bergh, Karin Haustermans, Steven Joniau, Evelyne Lerut, Liesbeth De Wever, Frederik De Keyzer, Tom Budiharto, Pieter Slagmolen, Hendrik Van Poppel, Raymond Oyen	2012	140
4	Primary endpoint analysis of the multicentre phase II hypo-FLAME trial for intermediate and high risk prostate cancer Radiotherapy and Oncology ·Cédric Draulans, Uulke A. van der Heide, Karin Haustermans, Floris J. Pos, Jochem van der Voort van Zyp, Hans de Boer, V. Groen, Evelyn M. Monninkhof, Robert Jan Smeenk, Martina Kunze-Busch, Robin De Roover, Tom Depuydt, Sofie Isebaert, Linda G.W. Kerkmeijer	2020	115
5	Standard whole prostate gland radiotherapy with and without lesion boost in prostate cancer: Toxicity in the FLAME randomized controlled trial Radiotherapy and Oncology ·Evelyn M. Monninkhof, Juliette W. L. van Loon, Marco van Vulpen, Linda G.W. Kerkmeijer, Floris J. Pos, Karin Haustermans, Laura Van den Bergh, Sofie Isebaert, G. McColl, Robert Jan Smeenk, Juus L Noteboom, Iris Walraven, Petra H.M. Peeters, Uulke A. van der Heide	2018	96
6	Hedgehog Signaling in Prostate Cancer and Its Therapeutic Implication International Journal of Molecular Sciences ·Annelies Gonnissen, Sofie Isebaert, Karin Haustermans	2013	84
7	Final analysis of a prospective trial on functional imaging for nodal staging in patients with prostate cancer at high risk for lymph node involvement Urologic Oncology Seminars and Original Investigations ·Laura Van den Bergh, Evelyne Lerut, Karin Haustermans, Christophe M. Deroose, Raymond Oyen, Sofie Isebaert, Tom Budiharto, Filip Ameye, Felix M. Mottaghy, Kris Bogaerts, Hendrik Van Poppel, Steven Joniau	2015	63
8	Mycotoxin‐producing Fusarium Species Occurring in Winter Wheat in Belgium (Flanders) During 2002–2005 Journal of Phytopathology ·Sofie Isebaert, Sarah De Saeger, Ruth DeVreese, Ruth Verhoeven, Peter Maene, Betty Heremans, Geert Haesaert	2008	53
9	Evaluation of semi-quantitative dynamic contrast-enhanced MRI parameters for prostate cancer in correlation to whole-mount histopathology European Journal of Radiology ·Sofie Isebaert, Frederik De Keyzer, Karin Haustermans, Evelyne Lerut, Tania Roskams, I. Roebben, Hendrik Van Poppel, Steven Joniau, Raymond Oyen	2011	52
10	A Systematic Assessment of Radiation Dose Enhancement by 5-Aza-2′-Deoxycytidine and Histone Deacetylase Inhibitors in Head-and-Neck Squamous Cell Carcinoma International Journal of Radiation OncologyBiologyPhysics ·Harlinde De Schutter, Marlies Kimpe, Sofie Isebaert, Sandra Nuyts	2009	47
11	Quantitative determination of the influence of adjuvants on foliar fungicide residues Crop Protection ·Bert Ryckaert, Pieter Spanoghe, Geert Haesaert, Betty Heremans, Sofie Isebaert, Walter Steurbaut	2007	40
12	Patterns of Failure Following External Beam Radiotherapy With or Without an Additional Focal Boost in the Randomized Controlled FLAME Trial for Localized Prostate Cancer European Urology ·V. Groen, Karin Haustermans, Floris J. Pos, Cédric Draulans, Sofie Isebaert, Evelyn M. Monninkhof, Robert Jan Smeenk, Martina Kunze-Busch, Johannes C.J. de Boer, Jochem van der Voort van Zijp, Linda G.W. Kerkmeijer, Uulke A. van der Heide	2021	38
13	Urethral and bladder dose–effect relations for late genitourinary toxicity following external beam radiotherapy for prostate cancer in the FLAME trial Radiotherapy and Oncology ·V. Groen, Marcel van Schie, Nicolaas P. A. Zuithoff, Evelyn M. Monninkhof, Martina Kunze-Busch, Johannes C.J. de Boer, Jochem van der Voort van Zijp, Floris J. Pos, Robert Jan Smeenk, Karin Haustermans, Sofie Isebaert, Cédric Draulans, Tom Depuydt, Helena M. Verkooijen, Uulke A. van der Heide, Linda G.W. Kerkmeijer	2021	36
14	The hedgehog inhibitor GANT61 sensitizes prostate cancer cells to ionizing radiation both in vitro and in vivo Oncotarget ·Annelies Gonnissen, Sofie Isebaert, Chad M. McKee, Rüveyda Dok, Karin Haustermans, Ruth J. Muschel	2016	36
15	Is There an Additional Value of 11C-Choline PET-CT to T2-weighted MRI Images in the Localization of Intraprostatic Tumor Nodules? International Journal of Radiation OncologyBiologyPhysics ·Laura Van den Bergh, Michel Koole, Sofie Isebaert, Steven Joniau, Christophe M. Deroose, Raymond Oyen, Evelyne Lerut, Tom Budiharto, Felix M. Mottaghy, Guy Bormans, Hendrik Van Poppel, Karin Haustermans	2012	35
16	Potential Molecular Mechanisms behind the Ultra-High Dose Rate “FLASH” Effect International Journal of Molecular Sciences ·Eva Bogaerts, Ellina Macaeva, Sofie Isebaert, Karin Haustermans	2022	30
17	Optimal 68Ga-PSMA and 18F-PSMA PET window levelling for gross tumour volume delineation in primary prostate cancer European Journal of Nuclear Medicine and Molecular Imaging ·Cédric Draulans, Robin De Roover, Uulke A. van der Heide, Linda G.W. Kerkmeijer, Robert Jan Smeenk, Floris J. Pos, Wouter V. Vogel, James Nagarajah, Marcel J. R. Janssen, Sofie Isebaert, Frederik Maes, Cindy Mai, Raymond Oyen, Steven Joniau, Martina Kunze-Busch, Karolien Goffin, Karin Haustermans	2020	28
18	DNA Methylation-Guided Prediction of Clinical Failure in High-Risk Prostate Cancer PLoS ONE ·Kirill Litovkin, Aleyde Van Eynde, Steven Joniau, Evelyne Lerut, Annouschka Laenen, Thomas Gevaert, Olivier Gevaert, Martin Spahn, Burkhard Kneitz, Pierre Gramme, Thibault Helleputte, Sofie Isebaert, Karin Haustermans, Mathieu Bollen	2015	28
19	The Effect of Metformin and GANT61 Combinations on the Radiosensitivity of Prostate Cancer Cells International Journal of Molecular Sciences ·Annelies Gonnissen, Sofie Isebaert, Chad M. McKee, Ruth J. Muschel, Karin Haustermans	2017	27
20	Stereotactic body radiation therapy with optional focal lesion ablative microboost in prostate cancer: Topical review and multicenter consensus Radiotherapy and Oncology ·Cédric Draulans, Robin De Roover, Uulke A. van der Heide, Karin Haustermans, Floris J. Pos, Robert Jan Smeenk, Hans de Boer, Tom Depuydt, Martina Kunze-Busch, Sofie Isebaert, Linda G.W. Kerkmeijer	2019	25

About Sofie Isebaert

Sofie Isebaert is a scholar working on Radiation, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Oncology and Rheumatology, having authored 63 papers that have together received 1.8k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (27 papers), Prostate Cancer Treatment and Research (24 papers), Advanced Radiotherapy Techniques (15 papers), Hedgehog Signaling Pathway Studies (8 papers), Epigenetics and DNA Methylation (8 papers), Radiomics and Machine Learning in Medical Imaging (8 papers), MRI in cancer diagnosis (5 papers) and Cancer-related Molecular Pathways (4 papers). The work is most often cited by research in Radiation (493 citations), Pulmonary and Respiratory Medicine (1.2k citations), Radiology, Nuclear Medicine and Imaging (470 citations), Rheumatology (160 citations) and Oncology (213 citations). Sofie Isebaert has collaborated with scholars based in Belgium, Netherlands and United States. Frequent co-authors include Karin Haustermans, Annelies Gonnissen, Laura Van den Bergh, Uulke A. van der Heide, Floris J. Pos, Robert Jan Smeenk, Linda G.W. Kerkmeijer, Steven Joniau, Cédric Draulans and Evelyn M. Monninkhof. Their work appears in journals such as Radiotherapy and Oncology, International Journal of Radiation Oncology*Biology*Physics, Acta Oncologica, International Journal of Molecular Sciences and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact